Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell (‘Berti’) lymphoma after administration of adalimumab Sarah M. Jacks, BA, Brent R. Taylor, MD, Raford P. Rogers, MD, Jonathan S. Ralston, MD, John S. Metcalf, MD, John Lazarchick, MD Journal of the American Academy of Dermatology Volume 71, Issue 3, Pages e86-e87 (September 2014) DOI: 10.1016/j.jaad.2014.03.022 Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 Primary aggressive CD8+ cytotoxic T-cell (Berti) lymphoma following adalimumab. Extremity with papulosquamous plaques clinically suggestive of psoriasis. Journal of the American Academy of Dermatology 2014 71, e86-e87DOI: (10.1016/j.jaad.2014.03.022) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Biopsy of an ulcer on the chest exhibited an epidermotropic CD8+ infiltrate of atypical T-cells. (Hematoxylin-eosin stain; original magnification ×10.) Journal of the American Academy of Dermatology 2014 71, e86-e87DOI: (10.1016/j.jaad.2014.03.022) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions